Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3752223013 | Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3752224019 | Lidocaine hydrochloride 10 mg/mL and methylprednisolone acetate 40 mg/mL suspension for injection | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has manufactured dose form | Conventional release suspension for injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has precise active ingredient | Methylprednisolone acetate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has basis of strength substance | Lidocaine hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Is a | Product containing only lidocaine and methylprednisolone in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has basis of strength substance | Methylprednisolone acetate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength numerator value | 40 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has basis of strength substance | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has precise active ingredient | Methylprednisolone acetate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) | Has basis of strength substance | Methylprednisolone acetate | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR